Health policy experts pushing for change in feds’ funding for research and development
By Mark BrownleeApr. 25, 2011
Federal and provincial governments currently give pharmaceutical companies tax breaks and subsidies to encourage them to devote more of their budgets to developing new drugs.
Health policy experts are pushing for changes to the federal government’s system of funding the research and development of new pharmaceuticals in the hopes of making drugs that are necessary to patients’ health more affordable.
People. Policy. Politics. This is an exclusive subscriber-only story.
‘Imagine losing your job, getting fired, but you’re fired by basically your entire riding and your whole life has been serving these people, and there’s just a lot wrapped up in it:’ Tory House leader Candice Bergen.
Jody Wilson-Raybould and Jane Philpott say they have no endgame, but some observers say they risk their reputations by continuing to find points of disagreement with Justin Trudeau, the government, and the Liberal Party.